Engineers Gate Manager LP Aravive, Inc. Transaction History

Engineers Gate Manager LP

  • $4.27 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$4.65 - $6.42 $65,100 - $89,880
-14,000 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$5.11 - $9.24 $71,540 - $129,360
14,000 New
14,000 $92,000
Q4 2020

Feb 16, 2021
SELL
$4.36 - $6.51 $54,936 - $82,026
-12,600 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$4.7 - $12.06 $59,220 - $151,956
12,600 New
12,600 $59,000

Others Institutions Holding ARAV

# of Institutions
2
Shares Held
28.1K
Call Options Held
0
Put Options Held
0
View Full List

About Aravive, Inc.

ARAV Quotes by TradingView
  • Ticker ARAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,518,300
  • Description
  • Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...
More about ARAV
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email